
Recomendações do Departamento de Neuroendocrinologia da Sociedade Brasileira de Endocrinologia e Metabologia para o Diagnóstico e Tratamento da Acromegalia no Brasil
2011; Editora da Universidade de São Paulo; Volume: 55; Issue: 9 Linguagem: Inglês
10.1590/s0004-27302011000900011
ISSN1677-9487
AutoresLeonardo Vieira Neto, Júlio Abucham, Luiz Antônio de Araújo, César Luiz Boguszewski, Marcello D. Bronstein, Mauro Antônio Czepielewski, Raquel S. Jallad, Nina Rosa de Castro Musolino, Luciana Ansaneli Naves, Antônio Ribeiro-Oliveira Júnior, Lúcio Vilar, Manuel dos Santos Faria, Mônica R. Gadelha,
Tópico(s)Ophthalmology and Eye Disorders
ResumoAcromegaly is a disease associated with increased morbidity and reduced life expectancy. Because of its insidious character and its non-recognition, the diagnosis is often made with delay, which, along with the complications related to GH/IGF-I excess, determines high morbidity and mortality. However, an early diagnosis and an effective treatment reduce the morbidity and normalize the mortality rate. In this publication, the goal of Neuroendocrinology Department from Brazilian Society of Endocrinology and Metabolism is to disclose which clinical set should arouse the suspicious of acromegaly and how to diagnose it. Furthermore, we discuss the most effective and safe approach to perform the treatment of acromegaly, emphasizing that it must be carried out in reference centers. Therefore, based on data published in journals with recognized scientific level and authors' experience, recommendations are presented for diagnosis and treatment of the disease.
Referência(s)